News FinancesAdenia Partners acquires a majority stake in Cairo-based Parkville Pharmaceuticals in its first deal in Egypt. The transaction marks Adenia’s entry into North Africa after a focus on sub-Saharan Africa. Adenia Partners announced on January 26, that it signed an agreement to acquire a majority stake in Parkville Pharmaceuticals, a Cairo-based company. Mahmoud Farrag, co-founder and chief executive officer of Parkville Pharmaceuticals, said: “We remain deeply committed […] to fostering a healthy and stimulating work environment for our employees and to delivering sustainable, long-term value to our investors who believe in Parkville’s vision. The transaction extends Adenia’s geographic footprint into North Africa after investments concentrated in sub-Saharan Africa.

Source: The North Africa Journal January 28, 2026 18:53 UTC